Anne Blaes, MD
Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Contact Info
Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation
Interim Division Director, Division of Hematology, Oncology and Transplantation
Director of Cancer Survivorship Services and Translational Research and Co-Leader SPECS, Masonic Cancer Center (MCC)
Section Lead, Medical Oncology
Hematologist / Oncologist
Medical School, Loyola University Chicago Stritch School of Medicine, Chicago, IL
Residency, University of Minnesota, Minneapolis, MN
Fellowship, University of Minnesota, Minneapolis, MN
Bachelor's Degree, University of Notre Dame, Notre Dame, IN
Summary
Dr. Anne Blaes is the Interim Division Director and an Associate Professor in the Division of Hematology and Oncology at the University of Minnesota. She is the section head of Medical Oncology within this division and is Director of Cancer Survivorship Services and Translational Research within the Masonic Cancer Center. She is an active medical oncologist with a special interest in the late effects of cancer therapy, particularly in the area of cardio-oncology. Her research focuses on designing and implementing strategies to help prevent the long term complications of treatments in our cancer survivors, particularly in the areas of cardiovascular health. She is the Chair for the American Society of Clinical Oncology’s Cancer Survivorship Committee, a member of the Executive Board for the Global Cardio-oncology Society, associate editor for JACC Cardio-oncology, section editor for Hem/Onc Today on Survivorship and an active member of the ALLIANCE for Cancer Clinical Trials.
Expertise
- Breast Cancer
- Cardiology
- Colorectal Cancer
- Cancer Survivorship
Awards & Recognition
University of Minnesota External Sources
Professional Associations
Medical Advisory Board
Research
Research Summary/Interests
Teaching
Academic Interests and Focus
Clinical
Clinics
Breast Center;Masonic Cancer Center
Clinical Interests
Breast cancer; Colorectal cancer; Cancer survivorship; Cardio-oncology